BMP2 and secondary hypertension: Morrell and colleagues [14] demonstrated that BMP-2 at doses of 1–100 ng/ml inhibited [3H] thymidine incorporation in PASMCs from normotensive and secondary pulmonary hypertension patients cultured in media that contained FBS.